Skip to main content
Chr. Hansen Holding logo

Chr. Hansen Holding — Investor Relations & Filings

Ticker · CHR ISIN · DK0060227585 LEI · 5493000W4VDBER5YIZ12 CO Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2016-04-12 Investor Presentation
Country DK Denmark
Listing CO CHR

About Chr. Hansen Holding

https://www.chr-hansen.com/en/

Chr. Hansen Holding A/S was a global bioscience company specializing in the development and production of natural microbial solutions. Its core business centered on leveraging fermentation technology and extensive bacterial libraries. The company's portfolio included cultures for food applications, probiotics for human and animal health, enzymes, and human milk oligosaccharides (HMOs). These ingredients were supplied to the food and beverage, nutritional, pharmaceutical, and agricultural industries to enhance product quality, improve health outcomes, and promote sustainable production.

Recent filings

Filing Released Lang Actions
Strategiopdatering - Nature's No. 1 reaffirmed
Investor Presentation Classification · 90% confidence The document is a company announcement from Chr. Hansen titled 'Nature’s No. 1 reaffirmed - strategy update'. It details long-term financial ambitions, strategic goals for various business segments (Food Cultures & Enzymes, Health & Nutrition, Natural Colors), and capital allocation principles. It explicitly mentions that this updated strategy will be presented at a 'Capital Markets Day' event. While it contains strategic information, it is not a full investor presentation deck, but rather a formal corporate announcement summarizing the strategy update. Given the focus on strategic direction and financial targets, it aligns best with the 'Investor Presentation' category as it serves as the textual summary of the Capital Markets Day materials.
2016-04-12 English
Strategiopdatering - Nature's No. 1 reaffirmed
Regulatory Filings Classification · 15% confidence The document is extremely brief (83 characters), contains no substantive financial data or detailed report content, and simply states “Company announcement No 06.” It does not attach or publish a full report, nor specify any specific regulatory form or meeting materials. It falls into the catch-all category for miscellaneous regulatory announcements.
2016-04-12 English
Hovedtal 2015/´16 ÅTD
Earnings Release Classification · 85% confidence The document is a press release titled “2015/16 YTD IN BRIEF” presenting key Q2 and half-year financial metrics (revenue, EBIT, profit, margins) along with commentary and outlook. It provides an initial announcement of interim financial results rather than a full statutory interim report. Therefore, it fits the definition of an Earnings Release (ER) rather than a full Interim/Quarterly Report. H1 2016
2016-04-07 English
Hovedtal 2015/´16 ÅTD
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'INTERIM REPORT 1 SEPTEMBER 2015 – 29 FEBRUARY 2016' and contains comprehensive financial statements, including income statements, balance sheets, cash flow data, and management analysis of financial results for the period. It is not an announcement of a report (RPA) nor a short summary, but the full interim financial report itself. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2016
2016-04-07 English
Hovedtal 2015/´16 ÅTD
Earnings Release Classification · 90% confidence The document is a press release by Chr. Hansen reporting first‐half 2015/16 and Q2 financial highlights (revenue, EBIT, margins, organic growth) along with management commentary and updated full‐year guidance. It does not include a full set of financial statements, but provides key metrics and outlook. This matches an initial Earnings Release (ER), not a full interim report (IR). H1 2016
2016-04-07 Danish
Chr. Hansen fuldfører opkøb af Nutrition Physiology
M&A Activity Classification · 100% confidence The document is a company announcement regarding the completion of an acquisition (Nutrition Physiology Company). It details the enterprise value, the strategic rationale, and the integration of the new business. This falls squarely under M&A activity (mergers and acquisitions).
2016-02-18 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.